BioCentury | Nov 24, 2014
Company News

Genomica S.A.U., Scienion sales and marketing update

...transmitted infections (STIs). Clart STIs A&Beta has CE Mark approval. Genomica S.A.U. , Madrid, Spain Scienion AG...
BioCentury | Oct 27, 2014
Company News

AIT Austrian Institute of Technology, BioVendor, Scienion deal

...AIT Austrian Institute of Technology, BioVendor and Scienion partnered to develop an in vitro diagnostic kit...
...blood. AIT is providing its patented, undisclosed biomarkers, BioVendor is providing its distribution network and Scienion...
...Institute of Technology GmbH , Vienna, Austria BioVendor Laboratorni medicina A.S. , Karasek, Czech Republic Scienion AG...
BioCentury | Sep 26, 2011
Finance

SQI looks south

...SQI's acquisition of German microarray company Scienion AG for about US$17 million in cash and stock. Scienion...
...and CEO Claude Ricks said the Scienion acquisition will allow SQI to expand European sales. Scienion...
...a four-person sales group in Europe. SQI has a three person sales team in total. Scienion...
BioCentury | Jun 25, 2009
Strategy

Science for export

...profiling services 2005 Martinsried, Germany $764K RNAx GmbH RNA screens 2002 Berlin, Germany Not available Scienion AG...
BioCentury | Feb 2, 2009
Company News

Scienion management update

Scienion AG , Berlin, Germany Business: Microarrays Hired: Guenter Bauer as CBO, formerly director of business collaboration at the PerkinElmer Cellular Technologies Germany GmbH subsidiary of PerkinElmer Inc. WIR Staff...
BioCentury | Sep 10, 2007
Company News

Scienion board of directors update

Scienion AG , Berlin, Germany Business: Microarrays Appointed: Timm Jessen, managing director at Scienamics GmbH WIR Staff...
BioCentury | Sep 19, 2005
Company News

BioDot Inc., Scienion deal

...BioDot received rights to distribute Scienion's products in North America. BioDot Inc. , Irvine, Calif. Scienion AG...
BioCentury | Dec 6, 2004
Company News

Scienion, Max Planck Institute for Molecular Genetics deal

...The institute granted Scienion exclusive rights to U.S. Patent No. 6,599,479, which covers the aspiration and...
...aspiration and release of ultra low-level liquid volumes by a piezoelectrically triggered multi-channel dispensing system. Scienion...
...MALDI mass spectrometry and the production of screening arrays loaded with chemicals and active agents. Scienion AG...
BioCentury | Sep 13, 2004
Emerging Company Profile

Scienion: Market-driven chips

...The biochip market is dominated by Affymetrix Inc. , but Scienion AG believes it has technology that...
...could make it profitable next year and obviate the need to raise more venture money. Scienion...
...they are actually expressed." For detection, Scienion can use both fluorescence and mass spectroscopy-based technologies. Scienion...
BioCentury | Sep 13, 2004
Emerging Company Profile

Corporate Profile

Scienion AG Berlin, Germany Technology: Generic and customized microarrays Disease focus: N/A Clinical status: N/A Founded: 2000 by Holger Eickhoff, Martin Horn, Wilfried Nietfeld, Hans Lehrach, Sebastian Delbrueck and Heike Feldkort Corporate partners: Agowa GmbH;...
Items per page:
1 - 10 of 13
BioCentury | Nov 24, 2014
Company News

Genomica S.A.U., Scienion sales and marketing update

...transmitted infections (STIs). Clart STIs A&Beta has CE Mark approval. Genomica S.A.U. , Madrid, Spain Scienion AG...
BioCentury | Oct 27, 2014
Company News

AIT Austrian Institute of Technology, BioVendor, Scienion deal

...AIT Austrian Institute of Technology, BioVendor and Scienion partnered to develop an in vitro diagnostic kit...
...blood. AIT is providing its patented, undisclosed biomarkers, BioVendor is providing its distribution network and Scienion...
...Institute of Technology GmbH , Vienna, Austria BioVendor Laboratorni medicina A.S. , Karasek, Czech Republic Scienion AG...
BioCentury | Sep 26, 2011
Finance

SQI looks south

...SQI's acquisition of German microarray company Scienion AG for about US$17 million in cash and stock. Scienion...
...and CEO Claude Ricks said the Scienion acquisition will allow SQI to expand European sales. Scienion...
...a four-person sales group in Europe. SQI has a three person sales team in total. Scienion...
BioCentury | Jun 25, 2009
Strategy

Science for export

...profiling services 2005 Martinsried, Germany $764K RNAx GmbH RNA screens 2002 Berlin, Germany Not available Scienion AG...
BioCentury | Feb 2, 2009
Company News

Scienion management update

Scienion AG , Berlin, Germany Business: Microarrays Hired: Guenter Bauer as CBO, formerly director of business collaboration at the PerkinElmer Cellular Technologies Germany GmbH subsidiary of PerkinElmer Inc. WIR Staff...
BioCentury | Sep 10, 2007
Company News

Scienion board of directors update

Scienion AG , Berlin, Germany Business: Microarrays Appointed: Timm Jessen, managing director at Scienamics GmbH WIR Staff...
BioCentury | Sep 19, 2005
Company News

BioDot Inc., Scienion deal

...BioDot received rights to distribute Scienion's products in North America. BioDot Inc. , Irvine, Calif. Scienion AG...
BioCentury | Dec 6, 2004
Company News

Scienion, Max Planck Institute for Molecular Genetics deal

...The institute granted Scienion exclusive rights to U.S. Patent No. 6,599,479, which covers the aspiration and...
...aspiration and release of ultra low-level liquid volumes by a piezoelectrically triggered multi-channel dispensing system. Scienion...
...MALDI mass spectrometry and the production of screening arrays loaded with chemicals and active agents. Scienion AG...
BioCentury | Sep 13, 2004
Emerging Company Profile

Scienion: Market-driven chips

...The biochip market is dominated by Affymetrix Inc. , but Scienion AG believes it has technology that...
...could make it profitable next year and obviate the need to raise more venture money. Scienion...
...they are actually expressed." For detection, Scienion can use both fluorescence and mass spectroscopy-based technologies. Scienion...
BioCentury | Sep 13, 2004
Emerging Company Profile

Corporate Profile

Scienion AG Berlin, Germany Technology: Generic and customized microarrays Disease focus: N/A Clinical status: N/A Founded: 2000 by Holger Eickhoff, Martin Horn, Wilfried Nietfeld, Hans Lehrach, Sebastian Delbrueck and Heike Feldkort Corporate partners: Agowa GmbH;...
Items per page:
1 - 10 of 13